Health outcome prioritization in Alzheimer’s disease: Understanding the ethical landscape

Manuscript Number: 

19-1300R2

Author(s): 
Zuzanna Angehrn, Dianne Gove, Alexander Keenan, Amanda Ly, Alex McKeown, Brent Mittelstadt, Mia Nelson, Clementine Nordon, Ilina Singh, Michael Smith, Claire Tochel, Andrew Turner

Disclosures

Zuzanna Angehrn

  • Consulting Fees:
    Certara's participation in the ROADMAP project was funded by Novartis.
    Equity:
    Roche Pharmaceuticals
    Sponsors:
    Certara's participation in the ROADMAP project was funded by Novartis.

Dianne Gove

  • Nothing to Disclose

Alexander Keenan

  • Equity:
    Johnson and Johnson
    Sponsors:
    Johnson and Johnson (provides funding to IMI)

Amanda Ly

  • Nothing to Disclose

Alex McKeown

  • Nothing to Disclose

Brent Mittelstadt

  • Nothing to Disclose

Mia Nelson

  • Nothing to Disclose

Clementine Nordon

  • Nothing to Disclose

Ilina Singh

  • Nothing to Disclose

Michael Smith

  • Nothing to Disclose

Claire Tochel

  • Nothing to Disclose

Andrew Turner

  • Nothing to Disclose